Objective
to determine if radial access is associated with better clinical outcome compared to standard femoral access in patients undergoing primary PCI
Study
investigator-driven, multicentre, open-label randomised trial
Population
patients with STEMI referred for primary PCI
Endpoints
all-cause mortality at 30 days
Conclusion
the 30-day all-cause mortality rate is not different between radial access and femoral access for the treatment of STEMI with primary PCI
Le May et al. JAMA-Cardiology. 2020;5:126-34
